Xenon Reports Q1 2026 Financial Results and Provides Business Update May 7, 2026 04:01PM
Xenon to Present at Upcoming Investor Conferences Apr 15, 2026 08:30AM
RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns' Mar 18, 2026 09:21AM
Xenon Pharmaceuticals closes $747.5 million public offering Mar 12, 2026 04:01PM
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares Mar 12, 2026 04:01PM


Mar 10, 2026 10:39PM Xenon Pharmaceuticals prices $650 million stock offering at $57 per share
Mar 10, 2026 10:39PM Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering
Mar 9, 2026 04:01PM Xenon Pharmaceuticals announces $500 million public offering
Mar 9, 2026 04:01PM Xenon Pharmaceuticals Announces Proposed Public Offering
Nov 16, 2025 03:00PM Where can biotech stocks go from here? RBC answers
Sep 11, 2025 08:18AM RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'
Jun 13, 2025 09:03AM Xenon Pharmaceuticals (XENE) PT Raised to $57 at RBC Capital
May 14, 2025 04:01PM Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference
May 13, 2025 09:46AM Xenon Pharmaceuticals (XENE) PT Lowered to $55 at RBC Capital
Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets
Nov 13, 2024 06:48AM Xenon Pharmaceuticals (XENE) PT Raised to $56 at RBC Capital
Jun 18, 2024 06:20AM RBC Capital Reiterates Outperform Rating on Xenon Pharmaceuticals (XENE)
May 7, 2024 04:01PM Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
Dec 4, 2023 04:16PM Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Nov 30, 2023 06:03AM Xenon Pharmaceuticals (XENE) prices upsized 8.46M share offering at $32.50
Nov 29, 2023 10:51PM Xenon Pharmaceuticals Announces Pricing of Upsized $300.0 Million Public Offering
Nov 29, 2023 04:05PM Xenon Pharmaceuticals (XENE) Announces $225M Proposed Public Offering
Nov 29, 2023 04:03PM Xenon Pharmaceuticals Announces Proposed Public Offering
May 11, 2023 04:01PM Xenon Pharmaceuticals to Present at the 2023 RBC Capital Markets Global Healthcare Conference
Apr 25, 2022 04:01PM Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
Apr 25, 2022 04:01PM Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
Oct 28, 2021 05:58AM UPDATE: RBC Capital Starts Xenon Pharmaceuticals (XENE) at Outperform
Oct 8, 2021 02:15PM Xenon Pharmaceuticals Announces Closing of $345 Million Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Oct 8, 2021 02:15PM Xenon Pharmaceuticals Announces Closing of $345 Million Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Oct 6, 2021 05:44AM Xenon Pharmaceuticals (XENE) Prices 8.47M Share Offering at $29.50/sh
Oct 5, 2021 09:54PM Xenon Pharmaceuticals Announces Pricing of $300.0 Million Public Offering
Oct 5, 2021 09:54PM Xenon Pharmaceuticals Announces Pricing of $300.0 Million Public Offering
Oct 4, 2021 04:08PM Xenon Pharmaceuticals (XENE) Announces $250M Proposed Public Offering of Common Shares
Oct 4, 2021 04:08PM Xenon Pharmaceuticals Announces Proposed Public Offering
Oct 4, 2021 04:08PM Xenon Pharmaceuticals Announces Proposed Public Offering